Related Experiment Video
Updated: Aug 11, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Inactivation of herpes simplex virus clinical isolates by using a combination microbicide
Charles E Isaacs1, Lisa Rohan, Weimin Xu
1Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314, USA. chisi@cunyvm.cuny.edu
Abstract:
A combination microbicide using the lipid-ether 1-0-octyl-sn-glycerol (OG) (3 mM) and peptide LSA5 (9 microM) synergistically inactivated six clinical isolates of herpes simplex virus type 2 (HSV-2) by 30- to 100-fold and five of six HSV-1 isolates by 10-fold more than the sum of OG and LSA5 used individually within 30 min. OG plus LSA5 inactivated all HSV clinical isolates by > or = 1,000-fold in 10 to 40 min.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Herpes
Genital Herpes
Chemical Agents for Microbial Control
Hand hygiene
Hand washing...
Antimicrobial Effectiveness

